| SCHB | Monday, March 26, 2007 | ||
8:00 AM-11:48 AM Hyatt Regency McCormick -- 23 A/B, Oral | |||
Interfacing Big Pharma with Emerging Technologies | |||
| Sponsored by: | SCHB | ||
| Cosponsored by: | Brinks, Hofer, Gilson & Lione: IP Law Worldwide | ||
| Organizer: | Michael Lefenfeld | ||
| 8:00 AM | Introductory Remarks | ||
| 8:05 AM | 3 | How to be David against Goliath: Competing with pharma on a shoestring budget K. Shannon Mrksich | |
| 8:35 AM | 4 | How to get a fair shake from pharma Peter Karabatsos | |
| 9:05 AM | 5 | Investing in emerging technologies: Harris & Harris Group's approach Daniel B Wolfe | |
| 9:35 AM | Intermission | ||
| 9:45 AM | 6 | Advancing R&D through modernization of software platforms Frank Brown | |
| 10:15 AM | 7 | Chemistry innovation at Sigma-Aldrich Christopher D. Hewitt | |
| 10:45 AM | 8 | Application of emerging technologies in pharmaceutical process research and development: Safe and efficient alternative to alkali metals Boris Gorin, Kiem Nguyen, Alan Qingbo Lu | |
| 11:15 AM | 9 | New products for chiral chemistry based on a novel nanotechnology approach Regina Valluzzi | |
| 11:45 AM | Concluding Remarks | ||
Interfacing Big Pharma with Emerging Technologies -- Next Session
Symposium Grid -- Division of Small Chemical Businesses -- Session Listing
The 233rd ACS National Meeting, Chicago, IL, March 25-29, 2007